1h Free Analyst Time
Insulin Delivery Devices - Medical Devices Pipeline Assessment, 2019Speak directly to the analyst to clarify any post sales queries you may have.
Summary
The author's Medical Devices sector report, “Insulin Delivery Devices - Medical Devices Pipeline Assessment, 2019" provides an overview of Insulin Delivery Devices currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Insulin Delivery Devices pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by the author's team of industry experts.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Insulin Delivery Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Insulin Delivery Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry.
Reasons to Buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Insulin Delivery Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date.
Table of Contents
1 Table of Contents
2 Introduction
3 Products under Development
4 Insulin Delivery Devices - Pipeline Products under Development by Companies
5 Insulin Delivery Devices Companies and Product Overview
6 Insulin Delivery Devices - Recent Developments
7 Appendix
List of Tables
List of Figures
Companies Mentioned
A selection of companies mentioned in this report includes:
- Amrita Vishwa Vidyapeetham
- Andain, Inc
- Animas Corp
- ASTI Corp
- Avecho Biotechnology Ltd
- Becton Dickinson and Co
- Bigfoot Biomedical Inc
- Biocon Ltd
- Cam Med LLC
- Cambridge Consultants Ltd
- Capillary Biomedical, Inc.
- Cellnovo Ltd
- CeQur SA
- Companion Medical Inc
- Dance Biopharm Inc
- Debiotech SA
- Defymed SAS
- Dermisonics Inc
- Eli Lilly and Co
- Emperra GmbH E-Health Technologies
- Hospira Inc
- Imagine Medical Device Inc.
- InsuLenz
- Insulet Corp
- InsuLine Medical Ltd
- Iowa State University
- LifeScan Inc
- MannKind Corp
- Medical International Technologies (Mit Canada) Inc
- MedPro Safety Products, Inc.
- MedSolve Technologies, Inc.
- Medtronic Diabetes
- Medtronic plc
- MicroPort Scientific Corp
- NanoDerma Ltd
- Nitto Denko Corp
- North Carolina State University
- Novo Nordisk AS
- Pennsylvania State University
- Phluid Corporation
- Prometheon Pharma LLC
- Sanofi
- SFC Fluidics LLC
- Spring Health Solutions Ltd.
- Tandem Diabetes Care Inc
- Terumo Corp
- Thermalin Inc
- Transdermal Specialties Inc
- University of KwaZulu-Natal
- University of Missouri-Kansas City
- University of North Carolina
- University of Toronto
- Univlabs Technologies Pvt Ltd
- Valeritas Inc
- ViCentra BV
- Vigmed Holding AB
- WaveForm Technologies Inc
- Ypsomed Holding AG
- Zealand Pharma AS